Reduction in Cerebrospinal Fluid Volume as an Early Quantitative Biomarker of Cerebral Edema After Ischemic Stroke.
brain
edema
glucose
neuroimaging
stroke
Journal
Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
11
12
2019
medline:
2
7
2020
entrez:
11
12
2019
Statut:
ppublish
Résumé
Background and Purpose- Cerebral edema (CED) develops in the hours to days after stroke; the resulting increase in brain volume may lead to midline shift (MLS) and neurological deterioration. The time course and implications of edema formation are not well characterized across the spectrum of stroke. We analyzed displacement of cerebrospinal fluid (ΔCSF) as a dynamic quantitative imaging biomarker of edema formation. Methods- We selected subjects enrolled in a stroke cohort study who presented within 6 hours of onset and had baseline and ≥1 follow-up brain computed tomography scans available. We applied a neural network-based algorithm to quantify hemispheric CSF volume at each imaging time point and modeled CSF trajectory over time (using a piecewise linear mixed-effects model). We evaluated ΔCSF within the first 24 hours as an early biomarker of CED (defined as developing MLS on computed tomography beyond 24 hours) and poor outcome (modified Rankin Scale score, 3-6). Results- We had serial imaging in 738 subjects with stroke, of whom 91 (13%) developed CED with MLS. Age did not differ (69 versus 70 years), but baseline National Institutes of Health Stroke Scale was higher (16 versus 7) and baseline CSF volume lower (132 versus 161 mL, both
Identifiants
pubmed: 31818229
doi: 10.1161/STROKEAHA.119.027895
pmc: PMC6991889
mid: NIHMS1549170
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-467Subventions
Organisme : NINDS NIH HHS
ID : U24 NS107230
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085419
Pays : United States
Organisme : NINDS NIH HHS
ID : P01 NS032636
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS084028
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS099440
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS099487
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS110699
Pays : United States
Références
Stroke. 2018 Aug;49(8):1906-1912
pubmed: 29976584
Stroke. 1984 May-Jun;15(3):492-6
pubmed: 6729878
Int J Epidemiol. 2001 Dec;30(6):1332-41
pubmed: 11821342
Crit Care Med. 2016 Jan;44(1):171-9
pubmed: 26308431
J Cereb Blood Flow Metab. 2017 Aug;37(8):3077-3084
pubmed: 28155584
Neurocrit Care. 2016 Aug;25(1):64-70
pubmed: 26703130
Neuron. 2013 Apr 24;78(2):256-68
pubmed: 23562540
Neuroimage. 2017 Jan;144(Pt B):287-293
pubmed: 26439514
Neurocrit Care. 2016 Jun;24(3):420-7
pubmed: 26438467
Int J Stroke. 2013 Oct;8(7):529-34
pubmed: 22405327
Neuroimage Clin. 2016 Sep 26;12:673-680
pubmed: 27761398
Stroke. 2001 Feb;32(2):442-7
pubmed: 11157180
Stroke. 2019 Nov;50(11):3021-3027
pubmed: 31537189
Crit Care Med. 2003 Jan;31(1):272-7
pubmed: 12545028
Ann Neurol. 2010 Oct;68(4):435-45
pubmed: 20865766
Arch Neurol. 1996 Apr;53(4):309-15
pubmed: 8929152
Neurology. 1995 Jul;45(7):1286-90
pubmed: 7617183
Stroke. 2014 Dec;45(12):3643-8
pubmed: 25336512
Front Neurol. 2018 Aug 21;9:687
pubmed: 30186224
Stroke. 2019 May 16;:STROKEAHA119024882
pubmed: 31092157
Lancet Neurol. 2007 Mar;6(3):215-22
pubmed: 17303527
Lancet Neurol. 2007 Mar;6(3):258-68
pubmed: 17303532
Stroke. 2001 Sep;32(9):2117-23
pubmed: 11546905
Stroke. 2011 Dec;42(12):3403-9
pubmed: 21903965
N Engl J Med. 1986 Apr 10;314(15):953-8
pubmed: 3960059
Neurology. 1999 Jan 1;52(1):45-9
pubmed: 9921847